Editas Medicine Inc (EDIT)

전일 마감가:

$5.22

열려 있는:

$5.25

하루 거래량:

1.35M

시가총액:

$437.49M

수익:

$78.12M

순이익/손실:

$-153.22M

주가수익비율:

-1.7973

EPS:

-2.96

순현금흐름:

$-136.90M

1주 성능:

-3.10%

1개월 성능:

-26.32%

6개월 성능:

-18.28%

1년 성능:

-32.66%

1일 변동 폭

$5.1299

$5.395

52주 변동 폭

$5.11

$11.91

Editas Medicine Inc Stock (EDIT) Company Profile

명칭

Editas Medicine Inc

부문

Healthcare (1191)

산업

Biotechnology (688)

전화

617-401-9000

주소

11 Hurley Street, Cambridge, MA

직원

112

트위터

@editasmed

다음 수익 날짜

2024-05-03

최신 SEC 제출 서류

EDIT's Discussions on Twitter

Editas Medicine Inc Stock (EDIT) Upgrades & Downgrades

날짜	액션	분석자	등급 변경
2023-06-12	업그레이드	Raymond James	Mkt Perform → Outperform
2023-02-01	개시	Cantor Fitzgerald	Overweight
2022-12-13	개시	Citigroup	Neutral
2022-12-06	재개	Credit Suisse	Neutral
2022-11-18	다운그레이드	Credit Suisse	Outperform → Neutral
2022-11-18	다운그레이드	Oppenheimer	Outperform → Perform
2022-09-29	개시	BofA Securities	Neutral
2021-10-19	개시	SVB Leerink	Mkt Perform
2021-09-24	개시	Stifel	Hold
2021-09-10	업그레이드	Oppenheimer	Perform → Outperform
2021-08-09	업그레이드	Truist	Hold → Buy
2021-08-05	업그레이드	Evercore ISI	Underperform → Outperform
2021-06-04	재개	Robert W. Baird	Outperform
2021-05-04	개시	RBC Capital Mkts	Sector Perform
2021-04-16	개시	Goldman	Sell
2021-03-22	개시	Credit Suisse	Outperform
2021-03-01	다운그레이드	Barclays	Overweight → Equal Weight
2021-02-26	다운그레이드	Truist	Buy → Hold
2021-01-19	다운그레이드	Morgan Stanley	Equal-Weight → Underweight
2021-01-07	다운그레이드	Raymond James	Outperform → Mkt Perform
2020-12-10	업그레이드	Wells Fargo	Equal Weight → Overweight
2020-11-03	개시	Robert W. Baird	Underperform
2020-06-18	재개	SunTrust	Buy
2020-02-21	개시	Wells Fargo	Equal Weight
2019-04-12	개시	Evercore ISI	Outperform
2018-10-10	개시	Guggenheim	Neutral
2018-09-21	개시	Raymond James	Outperform
2018-05-15	재확인	Chardan Capital Markets	Buy
2018-02-13	개시	CLSA	Underperform
2018-01-23	업그레이드	SunTrust	Hold → Buy
2017-07-14	개시	SunTrust	Hold
2017-03-28	개시	Chardan Capital Markets	Buy
2016-08-10	업그레이드	Jefferies	Hold → Buy
2016-06-02	개시	Jefferies	Hold
2016-02-29	개시	JMP Securities	Mkt Outperform
2016-02-29	개시	JP Morgan	Neutral
2016-02-29	개시	Morgan Stanley	Equal-Weight

모두보기

Editas Medicine Inc 주식(EDIT)의 최신 뉴스

Will Editas Medicine (EDIT) Report Negative Q1 Earnings? What You Should Know

Zacks Investment Research

Editas Medicine to Present Pre-clinical Data Demonstrating Progression of in vivo Medicines Pipeline at the American Society of Gene and Cell Therapy Annual Meeting

GlobeNewswire Inc.

Why Is Editas (EDIT) Down 26.2% Since Last Earnings Report?

Zacks Investment Research

1 Wall Street Analyst Raises Editas Medicine's Price Target by 45%. Here's Why She's Right.

The Motley Fool

1 Beaten-Down Stock With 55% Upside, According to Wall Street

The Motley Fool

Why Editas Medicine Stock Soared as Much as 42% Higher This Week

The Motley Fool

Editas Medicine Inc (EDIT) 재무 분석

Editas Medicine Inc (EDIT) 매출 2024

Editas Medicine Inc (EDIT) 순이익 2024

Editas Medicine Inc (EDIT) 현금흐름 2024

Editas Medicine Inc (EDIT) 주당 순이익 2024

Editas Medicine Inc 주식 (EDIT) 내부자 거래